224
Views
0
CrossRef citations to date
0
Altmetric
Research Article

The Quantitative Profiling of Blood mSEPT9 Determines the Detection Performance on Colorectal Tumors

, , , , , , , , , , , & show all
Pages 1569-1583 | Received 17 Nov 2017, Accepted 26 Feb 2018, Published online: 14 Nov 2018

References

  • Schreuders EH , RucoA , RabeneckLet al. Colorectal cancer screening: a global overview of existing programmes . Gut64 ( 10 ), 1637 – 1649 ( 2015 ).
  • Li Y , SongL , GongYet al. Detection of colorectal cancer by DNA methylation biomarker SEPT9: past, present and future . Biomark. Med.8 ( 5 ), 755 – 769 ( 2014 ).
  • Song L , LiY . SEPT9: a specific circulating biomarker for colorectal cancer . Adv. Clin. Chem.72 , 171 – 204 ( 2015 ).
  • Jin P , KangQ , WangXet al. Performance of a second-generation methylated SEPT9 test in detecting colorectal neoplasm . J. Gastroenterol. Hepatol.30 ( 5 ), 830 – 833 ( 2015 ).
  • Wu D , ZhouG , JinPet al. Detection of colorectal cancer using a simplified SEPT9 gene methylation assay is a reliable method for opportunistic screening . J. Mol. Diagn.18 ( 4 ), 535 – 45 ( 2016 ).
  • Song L , LiY , JiaJet al. Algorithm optimization in methylation detection with multiple RT-qPCR . PLoS ONE11 ( 11 ), e0163333 ( 2016 ).
  • Song L , JiaJ , YuHet al. The performance of the mSEPT9 assay is influenced by algorithm, cancer stage and age, but not sex and cancer location . J. Cancer Res. Clin. Oncol.143 ( 6 ), 1093 – 1101 ( 2017 ).
  • Grützmann R , MolnarB , PilarskyCet al. Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay . PLoS ONE3 ( 11 ), e3759 ( 2008 ).
  • deVos T , TetznerR , ModelFet al. Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer . Clin. Chem.55 ( 7 ), 1337 – 1346 ( 2009 ).
  • Warren JD , XiongW , BunkerAMet al. Septin 9 methylated DNA is a sensitive and specific blood test for colorectal cancer . BMC Med.9 , 133 ( 2011 ).
  • Tóth K , SiposF , KalmárAet al. Detection of methylated SEPT9 in plasma is a reliable screening method for both left- and right-sided colon cancers . PLoS ONE7 ( 9 ), e46000 ( 2012 ).
  • Church TR , WandellM , Lofton-DayCet al. Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer . Gut63 ( 2 ), 317 – 325 ( 2014 ).
  • Johnson DA , BarclayRL , MergenerKet al. Plasma Septin9 versus fecal immunochemical testing for colorectal cancer screening: a prospective multicenter study . PLoS ONE9 ( 6 ), e98238 ( 2014 ).
  • Song L , PengX , LiYet al. The SEPT9 gene methylation assay is capable of detecting colorectal adenoma in opportunistic screening . Epigenomics9 ( 5 ), 599 – 610 ( 2017 ).
  • Benson AB 3rd , Bekaii-SaabT , ChanEet al. Localized colon cancer, version 3.2013: featured updates to the NCCN Guidelines . J. Natl Compr. Canc. Netw.11 , 519 – 528 ( 2013 )
  • Bosman FT , CarneiroF , HrubanRH . WHO Classification of Tumours of the Digestive System (4th Edition) . Lyon: International Agency for Research on Cancer Press ( 2010 ).
  • Dietrich D , HasingerO , LiebenbergVet al. DNA methylation of the homeobox genes PITX2 and SHOX2 predicts outcome in non-small-cell lung cancer patients . Diagn. Mol. Pathol.21 , 93 – 104 ( 2012 ).
  • Wasserkort R , KalmarA , ValczGet al. Aberrant septin 9 DNA methylation in colorectal cancer is restricted to a single CpG island . BMC Cancer13 , 398 ( 2013 ).
  • Semaan A , van EllenA , MellerSet al. SEPT9 and SHOX2 DNA methylation status and its utility in the diagnosis of colonic adenomas and colorectal adenocarcinomas . Clin. Epigenetics8 , 100 ( 2016 ).
  • Potter NT , HurbanP , WhiteMNet al. Validation of a real-time PCR-based qualitative assay for the detection of methylated SEPT9 DNA in human plasma . Clin. Chem.60 ( 9 ), 1183 – 1191 ( 2014 ).
  • Hamakawa T , KukitaY , KurokawaYet al. Monitoring gastric cancer progression with circulating tumour DNA . Br. J. Cancer112 ( 2 ), 352 – 356 ( 2015 ).
  • Morelli MP , OvermanMJ , DasariAet al. Characterizing the patterns of clonal selection in circulating tumor DNA from patients with colorectal cancer refractory to anti-EGFR treatment . Ann. Oncol.26 ( 4 ), 731 – 736 ( 2015 ).
  • Imamura F , UchidaJ , KukitaYet al. Monitoring of treatment responses and clonal evolution of tumor cells by circulating tumor DNA of heterogeneous mutant EGFR genes in lung cancer . Lung Cancer94 , 68 – 73 ( 2016 ).
  • Reinert T , Sch⊘lerLV , ThomsenRet al. Analysis of circulating tumour DNA to monitor disease burden following colorectal cancer surgery . Gut65 ( 4 ), 625 – 634 ( 2016 ).
  • Tham C , ChewM , SoongRet al. Postoperative serum methylation levels of TAC1 and SEPT9 are independent predictors of recurrence and survival of patients with colorectal cancer . Cancer120 ( 20 ), 3131 – 3141 ( 2014 ).
  • de Vos L , GevenslebenH , SchröckAet al. Comparison of quantification algorithms for circulating cell-free DNA methylation biomarkers in blood plasma from cancer patients . Clin. Epigenetics9 , 125 ( 2017 ).
  • Sundberg SO , WittwerCT , ZhouL , PalaisR , DwightZ , GaleBK . Quasi-digital PCR: enrichment and quantification of rare DNA variants . Biomed. Microdevices16 , 639 – 644 ( 2014
  • Schröck A , LeisseA , de VosLet al. Free-circulating methylated DNA in blood for diagnosis, staging, prognosis, and monitoring of head and neck squamous cell carcinoma patients: an observational prospective cohort study . Clin. Chem.63 ( 7 ), 1288 – 1296 ( 2017 ).
  • Lee HS , HwangSM , KimTSet al. Circulating methylated septin 9 nucleic acid in the plasma of patients with gastrointestinal cancer in the stomach and colon . Transl. Oncol.6 ( 3 ), 290 – 296 ( 2013 ).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.